Citations (124)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Kendrick Qijun Li, Xu Shi, Wang Miao & Eric Tchetgen Tchetgen. (2023) Double Negative Control Inference in Test-Negative Design Studies of Vaccine Effectiveness. Journal of the American Statistical Association 0:0, pages 1-12.
Read now
Read now
Ruosu Zhang, Yuanjie Pang, Shiyu Wan, Ming Lu, Min Lv, Jiang Wu & Yangmu Huang. (2022) Effectiveness of influenza vaccination on in-hospital death in older adults with respiratory diseases. Human Vaccines & Immunotherapeutics 18:6.
Read now
Read now
Li Zhang, Mingwei Wei, Pengfei Jin, Jingxin Li & Fengcai Zhu. (2021) An evaluation of a test-negative design for EV-71 vaccine from a randomized controlled trial. Human Vaccines & Immunotherapeutics 17:7, pages 2101-2106.
Read now
Read now
Articles from other publishers (121)
Francisco Nogareda, Annette K. Regan, Paula Couto, Ashley L. Fowlkes, Radhika Gharpure, Sergio Loayza, Juliana Almeida Leite, Angel Rodríguez, Andrea Vicari, Eduardo Azziz-Baumgartner, Daniel Salas, María Fernanda Olivares Barraza, Natalia Vergara Mallegas, Paula Rodríguez Ferrari, Viviana Sotomayor Proschle, Rodrigo Fasce Pineda, Patricia Bustos Alister, Marcela Avendaño, Iván Brstilo, Roberto Arroba Tijerino, Guiselle Guzmán Saborío, Hebleen Brenes Porras, Lorena Gobern, Antonio Paredes, Maribel Cuyan, Claudia Estrada, Christa Leal, Liz Parra, Pablo Galindo, Lucas Santos, Raúl Francisco Pérez Tasigchana, Lucía Alexandra Astudillo Vallejo, Alfredo Bruno Caicedo, Alvaro Whittenbury, Marta Von Horoch, Silvia Battaglia, Chavely Domínguez, Elena Penayo, Cynthia Vázquez, Maria José Ortega, Fabiana Michel, María Emilia Nieto, Dahiana Tritten, Viviana Ramas, Natalia Goñi & Héctor Chiparelli. (2023) Effectiveness of COVID-19 vaccines against hospitalisation in Latin America during three pandemic waves, 2021–2022: a test-negative case-control design. The Lancet Regional Health - Americas 27, pages 100626.
Crossref
Crossref
Iván Martínez-Baz, Miguel Fernández-Huerta, Ana Navascués, Francisco Pozo, Camino Trobajo-Sanmartín, Itziar Casado, Aitziber Echeverria, Carmen Ezpeleta & Jesús Castilla. (2023) Influenza Vaccine Effectiveness in Preventing Laboratory-Confirmed Influenza Cases and Hospitalizations in Navarre, Spain, 2022–2023. Vaccines 11:9, pages 1478.
Crossref
Crossref
Sheena G. Sullivan, Arseniy Khvorov, Xiaotong Huang, Can Wang, Kylie E. C. Ainslie, Joshua Nealon, Bingyi Yang, Benjamin J. Cowling & Tim K. Tsang. (2023) The need for a clinical case definition in test-negative design studies estimating vaccine effectiveness. npj Vaccines 8:1.
Crossref
Crossref
Annalisa Rosso, Maria Elena Flacco, Graziella Soldato, Giuseppe Di Martino, Cecilia Acuti Martellucci, Roberto Carota, Marco De Benedictis, Graziano Di Marco, Rossano Di Luzio, Matteo Fiore, Antonio Caponetti & Lamberto Manzoli. (2023) COVID-19 Vaccination Effectiveness in the General Population of an Italian Province: Two Years of Follow-Up. Vaccines 11:8, pages 1325.
Crossref
Crossref
João Paulo Martins, Marlene Santos, André Martins, Miguel Felgueiras & Rui Santos. (2023) Seasonal Influenza Vaccine Effectiveness in Persons Aged 15–64 Years: A Systematic Review and Meta-Analysis. Vaccines 11:8, pages 1322.
Crossref
Crossref
Huong Le, Nicholas de Klerk, Christopher C Blyth, Heather Gidding, Parveen Fathima & Hannah C Moore. (2023) Non-specific benefit of seasonal influenza vaccine on respiratory syncytial virus-hospitalisations in children: An instrumental variable approach using population-based data. Vaccine 41:34, pages 5029-5036.
Crossref
Crossref
Michelle E Roh, Issaka Zongo, Alassane Haro, Liusheng Huang, Anyirékun Fabrice Somé, Rakiswendé Serge Yerbanga, Melissa D Conrad, Erika Wallender, Jennifer Legac, Francesca Aweeka, Jean-Bosco Ouédraogo & Philip J Rosenthal. (2023) Seasonal Malaria Chemoprevention Drug Levels and Drug Resistance Markers in Children With or Without Malaria in Burkina Faso: A Case-Control Study. The Journal of Infectious Diseases.
Crossref
Crossref
Paolo Eusebi, Niko Speybroeck, Sonja Hartnack, Jacob Stærk-Østergaard, Matthew J. Denwood & Polychronis Kostoulas. (2023) Addressing misclassification bias in vaccine effectiveness studies with an application to Covid-19. BMC Medical Research Methodology 23:1.
Crossref
Crossref
Anke L. Stuurman, Miriam Levi, Philippe Beutels, Hélène Bricout, Alexandre Descamps, Gaël Dos Santos, Ian McGovern, Ainara Mira‐Iglesias, Jos Nauta, Laurence Torcel‐Pagnon & Jorne Biccler. (2022) Investigating confounding in network‐based test‐negative design influenza vaccine effectiveness studies—Experience from the DRIVE project. Influenza and Other Respiratory Viruses 17:1.
Crossref
Crossref
Haruka Maeda, Nobuo Saito, Ataru Igarashi, Masayuki Ishida, Kazuya Suami, Ai Yagiuchi, Yuya Kimura, Masaru Komino, Hiromi Arai, Toru Morikawa, Iori Motohashi, Rei Miyazawa, Tetsu Moriyama, Hiroshi Kamura, Mayumi Terada, Osamu Kuwamitsu, Tomoichiro Hayakawa, Eiichiro Sando, Yasuji Ohara, Osamu Teshigahara, Motoi Suzuki & Konosuke Morimoto. (2022) Effectiveness of Messenger RNA Coronavirus Disease 2019 Vaccines Against Symptomatic Severe Acute Respiratory Syndrome Coronavirus 2 Infections During the Delta Variant Epidemic in Japan: Vaccine Effectiveness Real-time Surveillance for SARS-CoV-2 (VERSUS). Clinical Infectious Diseases 75:11, pages 1971-1979.
Crossref
Crossref
Clara Mazagatos, Concepción Delgado‐Sanz, Susana Monge, Francisco Pozo, Jesús Oliva, Virginia Sandonis, Ana Gandarillas, Carmen Quiñones‐Rubio, Cristina Ruiz‐Sopeña, Virtudes Gallardo‐García, Luca Basile, María Isabel Barranco‐Boada, Olga Hidalgo‐Pardo, Olalla Vazquez‐Cancela, Miriam García‐Vázquez, Amelia Fernández‐Sierra, Ana Milagro‐Beamonte, María Ordobás, Eva Martínez‐Ochoa, Socorro Fernández‐Arribas, Nicola Lorusso, Ana Martínez, Ana García‐Fulgueiras, Bartolomé Sastre‐Palou, Isabel Losada‐Castillo, Silvia Martínez‐Cuenca, Mar Rodríguez‐del Águila, Miriam Latorre & Amparo Larrauri. (2022) COVID‐19 vaccine effectiveness against hospitalization due to SARS‐CoV‐2: A test‐negative design study based on Severe Acute Respiratory Infection (SARI) sentinel surveillance in Spain. Influenza and Other Respiratory Viruses 16:6, pages 1014-1025.
Crossref
Crossref
Nicki L. Boddington, Punam Mangtani, Hongxin Zhao, Neville Q. Verlander, Joanna Ellis, Nick Andrews & Richard G. Pebody. (2022) Live‐attenuated influenza vaccine effectiveness against hospitalization in children aged 2–6 years, the first three seasons of the childhood influenza vaccination program in England, 2013/14–2015/16. Influenza and Other Respiratory Viruses 16:5, pages 897-905.
Crossref
Crossref
Naila Qamar, Gul Rukh & Sadiq N. Khan. (2022) Vaccines for Covid‐19: An insight on their effectiveness and adverse effects. Journal of Medical Virology 94:8, pages 3554-3560.
Crossref
Crossref
Carl A B Pearson, W John Edmunds, Thomas J Hladish & Rosalind M Eggo. (2022) Potential test-negative design study bias in outbreak settings: application to Ebola vaccination in Democratic Republic of Congo. International Journal of Epidemiology 51:1, pages 265-278.
Crossref
Crossref
Ulrike Baum, Sangita Kulathinal & Kari Auranen. (2021) Mitigation of biases in estimating hazard ratios under non-sensitive and non-specific observation of outcomes–applications to influenza vaccine effectiveness. Emerging Themes in Epidemiology 18:1.
Crossref
Crossref
Sukhyun Ryu & Benjamin J. Cowling. (2021) Human Influenza Epidemiology. Cold Spring Harbor Perspectives in Medicine 11:12, pages a038356.
Crossref
Crossref
Mark G. Thompson, Giselle Soto, Alon Peretz, Gabriella Newes-Adeyi, Young M. Yoo, Avital Hirsch, Mark A. Katz, Yeny Tinoco, Yonat Shemer Avni, Eduardo Ticona, Ryan Malosh, Emily Martin, Eduardo Matos, Sue Reynolds, Meredith Wesley, Jill Ferdinands, Angela Cheung, Min Levine, Eduar Bravo, Carmen Sofia Arriola, Maria Ester Castillo, Juan Carlos Castro, Fatimah Dawood, David Greenberg, Joan Manuel Neyra Quijandría, Eduardo Azziz-Baumgartner, Arnold Monto & Ran D. Balicer. (2021) Influenza vaccine effectiveness within prospective cohorts of healthcare personnel in Israel and Peru 2016–2019. Vaccine 39:47, pages 6956-6967.
Crossref
Crossref
Amit Bansal, Mai-Chi Trieu, Kristin G. I. Mohn & Rebecca Jane Cox. (2021) Safety, Immunogenicity, Efficacy and Effectiveness of Inactivated Influenza Vaccines in Healthy Pregnant Women and Children Under 5 Years: An Evidence-Based Clinical Review. Frontiers in Immunology 12.
Crossref
Crossref
Shuo Feng, Sheena G Sullivan, Eric J Tchetgen Tchetgen & Benjamin J Cowling. (2021) The Causal Interpretation of “Overall Vaccine Effectiveness” in Test-Negative Studies. American Journal of Epidemiology 190:10, pages 1993-1999.
Crossref
Crossref
Hannah Chung, Sarah A Buchan, Aaron Campigotto, Michael A Campitelli, Natasha S Crowcroft, Vinita Dubey, Jonathan B Gubbay, Timothy Karnauchow, Kevin Katz, Allison J McGeer, J Dayre McNally, Samira Mubareka, Michelle Murti, David C Richardson, Laura C Rosella, Kevin L Schwartz, Marek Smieja, George Zahariadis & Jeffrey C Kwong. (2021) Influenza Vaccine Effectiveness Against All-Cause Mortality Following Laboratory-Confirmed Influenza in Older Adults, 2010–2011 to 2015–2016 Seasons in Ontario, Canada. Clinical Infectious Diseases 73:5, pages e1191-e1199.
Crossref
Crossref
Iuliana Ciocănea-Teodorescu, Martha Nason, Arvid Sjölander & Erin E Gabriel. (2021) Adjustment for Disease Severity in the Test-Negative Study Design. American Journal of Epidemiology 190:9, pages 1882-1889.
Crossref
Crossref
Minal K. Patel, Isabel Bergeri, Joseph S. Bresee, Benjamin J. Cowling, Natasha S. Crowcroft, Kamal Fahmy, Siddhivinayak Hirve, Gagandeep Kang, Mark A. Katz, Claudio F. Lanata, Maïna L'Azou Jackson, Sudhir Joshi, Marc Lipsitch, Jason M. Mwenda, Francisco Nogareda, Walter A. Orenstein, Justin R. Ortiz, Richard Pebody, Stephanie J. Schrag, Peter G. Smith, Padmini Srikantiah, Lorenzo Subissi, Marta Valenciano, David W. Vaughn, Jennifer R. Verani, Annelies Wilder-Smith & Daniel R. Feikin. (2021) Evaluation of post-introduction COVID-19 vaccine effectiveness: Summary of interim guidance of the World Health Organization. Vaccine 39:30, pages 4013-4024.
Crossref
Crossref
Monika Kuliese, Aukse Mickiene, Ligita Jancoriene, Birute Zablockiene & Giedre Gefenaite. (2021) Age-Specific Seasonal Influenza Vaccine Effectiveness against Different Influenza Subtypes in the Hospitalized Population in Lithuania during the 2015–2019 Influenza Seasons. Vaccines 9:5, pages 455.
Crossref
Crossref
Sheena G Sullivan. (2020) The Need for Robust Epidemiological Evidence During a Pandemic. Clinical Infectious Diseases 71:16, pages 2289-2290.
Crossref
Crossref
Natalie E Dean, M Elizabeth Halloran & Ira M Longini, Jr. (2020) Temporal Confounding in the Test-Negative Design. American Journal of Epidemiology 189:11, pages 1402-1407.
Crossref
Crossref
Eleftheria Vasileiou, Aziz Sheikh, Chris C Butler, Chris Robertson, Kimberley Kavanagh, Tanya Englishby, Nazir I Lone, Beatrix von Wissmann, Jim McMenamin, Lewis D Ritchie, Jürgen Schwarze, Rory Gunson & Colin R Simpson. (2020) Seasonal Influenza Vaccine Effectiveness in People With Asthma: A National Test-Negative Design Case-Control Study. Clinical Infectious Diseases 71:7, pages e94-e104.
Crossref
Crossref
Ulrike Baum, Kari Auranen, Sangita Kulathinal, Ritva Syrjänen, Hanna Nohynek & Jukka Jokinen. (2018) Cohort study design for estimating the effectiveness of seasonal influenza vaccines in real time based on register data: The Finnish example. Scandinavian Journal of Public Health 48:3, pages 316-322.
Crossref
Crossref
Markos Kalligeros, Fadi Shehadeh, Evangelia K. Mylona, Christine Dapaah-Afriyie, Robertus van Aalst, Ayman Chit & Eleftherios Mylonakis. (2020) Influenza vaccine effectiveness against influenza-associated hospitalization in children: A systematic review and meta-analysis. Vaccine 38:14, pages 2893-2903.
Crossref
Crossref
Monica L Nation, Robert Moss, Matthew J Spittal, Tom Kotsimbos, Paul M Kelly & Allen C Cheng. (2020) Influenza Vaccine Effectiveness Against Influenza-Related Mortality in Australian Hospitalized Patients: A Propensity Score Analysis. Clinical Infectious Diseases.
Crossref
Crossref
Huiying Chua, Shuo Feng, Joseph A. Lewnard, Sheena G. Sullivan, Christopher C. Blyth, Marc LipsitchBenjamin J. Cowling. (2020) The Use of Test-negative Controls to Monitor Vaccine Effectiveness. Epidemiology 31:1, pages 43-64.
Crossref
Crossref
A. Endo, S. Funk & A. J. Kucharski. (2020) Bias correction methods for test-negative designs in the presence of misclassification. Epidemiology and Infection 148.
Crossref
Crossref
Mark G. Thompson, De-Kun Li, Allison L. Naleway, Jeannette R. Ferber, Michelle L. Henninger, Pat Shifflett, Leslie Z. Sokolow, Roxana Odouli, Tia L. Kauffman, Rebecca V. Fink, Joanna Bulkley, Janet D. Cragan & Sam Bozeman. (2019) Factors associated with recruitment, surveillance participation, and retention in an observational study of pregnant women and influenza. BMC Pregnancy and Childbirth 19:1.
Crossref
Crossref
Carmen Sofia Arriola, Nathalie El Omeiri, Eduardo Azziz-Baumgartner, Mark G. Thompson, Viviana Sotomayor-Proschle, Rodrigo A. Fasce, Martha Von Horoch, José Enrique Carrizo Olalla, Walquíria Aparecida Ferreira de Almeida, Jacqueline Palacios, Rakhee Palekar, Paula Couto, Miguel Descalzo, Alba María Ropero-Álvarez, Cecilia Gonzalez, Sergio Loayza, Natalia Vergara, Patricia Bustos, Winston Andrade, Carla Magda S. Domingues, Ernesto Issac Montenegro Renoiner, Érica Tatiane da Silva, Swamy Lima Palmeira, Daiana Araujo da Silva, Ana Carolina de Lacerda Sousa, Marilda Mendonça Siqueira, Cynthia Vazquez, Silvia Battaglia, Carla Vizzotti, Elsa Baumeister, Carlos Giovacchini, Nathalia Katz, Oscar Pacheco, Juliana Barbosa, Diana Malo, Paola Pulido, Diego Garcia & Consuelo Pinzón. (2019) Influenza vaccine effectiveness against hospitalizations in children and older adults—Data from South America, 2013–2017. A test negative design. Vaccine: X 3, pages 100047.
Crossref
Crossref
Sheena G Sullivan, Carmen S Arriola, Judy Bocacao, Pamela Burgos, Patricia Bustos, Kylie S Carville, Allen C Cheng, Monique BM Chilver, Cheryl Cohen, Yi-Mo Deng, Nathalie El Omeiri, Rodrigo A Fasce, Orienka Hellferscee, Q Sue Huang, Cecilia Gonzalez, Lauren Jelley, Vivian KY Leung, Liza Lopez, Johanna M McAnerney, Andrea McNeill, Maria F Olivares, Heidi Peck, Viviana Sotomayor, Stefano Tempia, Natalia Vergara, Anne von Gottberg, Sibongile Walaza & Timothy Wood. (2019) Heterogeneity in influenza seasonality and vaccine effectiveness in Australia, Chile, New Zealand and South Africa: early estimates of the 2019 influenza season. Eurosurveillance 24:45.
Crossref
Crossref
Cheryl Cohen & Marta C Nunes. (2019) Vaccinating Mothers to Protect Their Babies Against Influenza. The Journal of Infectious Diseases.
Crossref
Crossref
Phillip S. Blanchette, Hannah Chung, Kathleen I. Pritchard, Craig C. Earle, Michael A. Campitelli, Sarah A. Buchan, Kevin L. Schwartz, Natasha S. Crowcroft, Jonathan B. Gubbay, Timothy Karnauchow, Kevin Katz, Allison J. McGeer, James D. McNally, David C. Richardson, Susan E. Richardson, Laura C. Rosella, Andrew Simor, Marek Smieja, George Zahariadis, Aaron Campigotto & Jeffrey C. Kwong. (2019) Influenza Vaccine Effectiveness Among Patients With Cancer: A Population-Based Study Using Health Administrative and Laboratory Testing Data From Ontario, Canada. Journal of Clinical Oncology 37:30, pages 2795-2804.
Crossref
Crossref
Huiying Chua, Susan S Chiu, Eunice L Y Chan, Shuo Feng, Mike Y W Kwan, Joshua S C Wong, J S Malik Peiris & Benjamin J Cowling. (2019) Effectiveness of Partial and Full Influenza Vaccination Among Children Aged <9 Years in Hong Kong, 2011–2019. The Journal of Infectious Diseases 220:10, pages 1568-1576.
Crossref
Crossref
Yu Li, Yonghong Zhou, Yibing Cheng, Peng Wu, Chongchen Zhou, Peng Cui, Chunlan Song, Lu Liang, Fang Wang, Qi Qiu, Chun Guo, Mengyao Zeng, Lu Long, Benjamin J Cowling & Hongjie Yu. (2019) Effectiveness of EV-A71 vaccination in prevention of paediatric hand, foot, and mouth disease associated with EV-A71 virus infection requiring hospitalisation in Henan, China, 2017–18: a test-negative case-control study. The Lancet Child & Adolescent Health 3:10, pages 697-704.
Crossref
Crossref
Jill M Ferdinands, Manjusha Gaglani, Emily T Martin, Don Middleton, Arnold S Monto, Kempapura Murthy, Fernanda P Silveira, H Keipp Talbot, Richard Zimmerman, Elif Alyanak, Courtney Strickland, Sarah Spencer, Alicia M Fry, Manjusha Gaglani, Tresa McNeal, Anne Robertson, Arundhati Rao, Kevin Chang, Kimberly Walker, Meredith Wimberly, Kempapura Murthy, Laurel Kilpatrick, Shekhar Ghamande, Alejandro Arroliga, Richard Zimmerman, Donald Middleton, Fernanda Silveira, Heather Eng, Theresa Sax, Julie Paronish, Sean Saul, Balasubramani Goundappa, Mary Patricia Nowalk, Charles RinaldoJrJr, Arlene Bullota, Lori Steiffel, Diana Pakstis, Arnold Monto, Emily Martin, Ryan Malosh, Joshua Petrie, Adam Lauring, Caroline Cheng, Hannah Segaloff, E J McSpadden, Emileigh Johnson, Rachel Truscon, Lois Lamerato, Susan Davis, Marcus Zervos, H Keipp Talbot, Dayna Wyatt, Yuwei Zhu, Zhouwen Liu, Rendie McHenry, Marie Griffin, Natasha Halasa, Sandra Alvarez Calvillo, Stephanie Longmire, Erin Zipperer, Laura Stewart, Jill Ferdinands, Alicia Fry, Elif Alyanak, Courtney Strickland, Sarah Spencer, Brendan Flannery, Jessie Chung, Xiyan Xu, Stephen Lindstrom, LaShondra Berman, Wendy Sessions & Rebecca Kondor. (2019) Prevention of Influenza Hospitalization Among Adults in the United States, 2015–2016: Results From the US Hospitalized Adult Influenza Vaccine Effectiveness Network (HAIVEN). The Journal of Infectious Diseases 220:8, pages 1265-1275.
Crossref
Crossref
Ainara Mira-Iglesias, F Xavier López-Labrador, Víctor Baselga-Moreno, Miguel Tortajada-Girbés, Juan Mollar-Maseres, Mario Carballido-Fernández, Germán Schwarz-Chavarri, Joan Puig-Barberà & Javier Díez-Domingo. (2019) Influenza vaccine effectiveness against laboratory-confirmed influenza in hospitalised adults aged 60 years or older, Valencia Region, Spain, 2017/18 influenza season. Eurosurveillance 24:31.
Crossref
Crossref
Jeffrey C. Kwong, Sarah A. Buchan, Hannah Chung, Michael A. Campitelli, Kevin L. Schwartz, Natasha S. Crowcroft, Michael L. Jackson, Timothy Karnauchow, Kevin Katz, Allison J. McGeer, J. Dayre McNally, David C. Richardson, Susan E. Richardson, Laura C. Rosella, Andrew Simor, Marek Smieja, George Zahariadis, Aaron Campigotto & Jonathan B. Gubbay. (2019) Can routinely collected laboratory and health administrative data be used to assess influenza vaccine effectiveness? Assessing the validity of the Flu and Other Respiratory Viruses Research (FOREVER) Cohort. Vaccine 37:31, pages 4392-4400.
Crossref
Crossref
Olivia H Price, Kylie S Carville & Sheena G Sullivan. (2019) Right sizing for vaccine effectiveness studies: how many is enough for reliable estimation?. Communicable Diseases Intelligence 43.
Crossref
Crossref
G Thomas Ray, Ned Lewis, Nicola P Klein, Matthew F Daley, Shirley V Wang, Martin Kulldorff & Bruce Fireman. (2019) Intraseason Waning of Influenza Vaccine Effectiveness. Clinical Infectious Diseases 68:10, pages 1623-1630.
Crossref
Crossref
Michael Haber, Benjamin A. Lopman, Jacqueline E. Tate, Meng Shi & Umesh D. Parashar. (2019) Effect of propensity of seeking medical care on the bias of the estimated effectiveness of rotavirus vaccines from studies using a test-negative case-control design. Vaccine 37:24, pages 3229-3233.
Crossref
Crossref
Mark G Thompson, Jeffrey C Kwong, Annette K Regan, Mark A Katz, Steven J Drews, Eduardo Azziz-Baumgartner, Nicola P Klein, Hannah Chung, Paul V Effler, Becca S Feldman, Kimberley Simmonds, Brandy E Wyant, Fatimah S Dawood, Michael L Jackson, Deshayne B Fell, Avram Levy, Noam Barda, Lawrence W Svenson, Rebecca V Fink, Sarah W Ball, Allison Naleway, Shikha Garg, Pat Shifflet, Sarah A Buchan, Stephanie M Booth, Margaret L Russel, Dan Riesel, Aharona Glatman-Freedman, Michal Mandelboim, Maya Leventer-Roberts, Stephanie Irving, Brad Crane, Ned Lewis, Kristin Goddard & Sharareh Modaressi. (2019) Influenza Vaccine Effectiveness in Preventing Influenza-associated Hospitalizations During Pregnancy: A Multi-country Retrospective Test Negative Design Study, 2010–2016. Clinical Infectious Diseases 68:9, pages 1444-1453.
Crossref
Crossref
Rajeev Rudraraju, Francesca Mordant & Kanta Subbarao. (2019) How Live Attenuated Vaccines Can Inform the Development of Broadly Cross-Protective Influenza Vaccines. The Journal of Infectious Diseases 219:Supplement_1, pages S81-S87.
Crossref
Crossref
Nicholas P Jewell, Suzanne Dufault, Zoe Cutcher, Cameron P Simmons & Katherine L Anders. (2019) Analysis of cluster-randomized test-negative designs: cluster-level methods. Biostatistics 20:2, pages 332-346.
Crossref
Crossref
Daitao Zhang, Yi Zhang, Quanyi Wang, Jerome Lock, Yang Pan, Shujuan Cui, Peng Yang & Yonghua Hu. (2019) The effectiveness of influenza vaccination in preventing hospitalizations in elderly in Beijing, 2016–18. Vaccine 37:13, pages 1853-1858.
Crossref
Crossref
Kylie E C Ainslie, Meng Shi, Michael Haber & Walter A Orenstein. (2019) A Dynamic Model for Evaluation of the Bias of Influenza Vaccine Effectiveness Estimates From Observational Studies. American Journal of Epidemiology 188:2, pages 451-460.
Crossref
Crossref
Susan S Chiu, Mike YW Kwan, Shuo Feng, Eunice LY Chan, Huiying Chua, Joshua SC Wong, JS Malik Peiris & Benjamin J Cowling. (2019) Early season estimate of influenza vaccination effectiveness against influenza hospitalisation in children, Hong Kong, winter influenza season 2018/19. Eurosurveillance 24:5.
Crossref
Crossref
Sheena G. Sullivan, Olivia H. Price & Annette K. Regan. (2019) Burden, effectiveness and safety of influenza vaccines in elderly, paediatric and pregnant populations. Therapeutic Advances in Vaccines and Immunotherapy 7, pages 251513551982648.
Crossref
Crossref
N. L. Boddington, F. Warburton, H. Zhao, N. Andrews, J. Ellis, M. Donati & R. G. Pebody. (2019) Influenza vaccine effectiveness against hospitalisation due to laboratory-confirmed influenza in children in England in the 2015–2016 influenza season – a test-negative case–control study. Epidemiology and Infection 147.
Crossref
Crossref
Annette K. Regan, Robyn Gibbs, Lauren Bloomfield & Paul V. Effler. (2019) Estimating influenza vaccine effectiveness using data routinely available in electronic primary care records. Vaccine 37:5, pages 755-762.
Crossref
Crossref
Stefano Aliberti, Charles S Dela Cruz, Giovanni Sotgiu & Marcos I Restrepo. (2019) Pneumonia is a neglected problem: it is now time to act. The Lancet Respiratory Medicine 7:1, pages 10-11.
Crossref
Crossref
Katherine L. Anders, Citra Indriani, Riris Andono Ahmad, Warsito Tantowijoyo, Eggi Arguni, Bekti Andari, Nicholas P. Jewell, Edwige Rances, Scott L. O’Neill, Cameron P. Simmons & Adi Utarini. (2018) The AWED trial (Applying Wolbachia to Eliminate Dengue) to assess the efficacy of Wolbachia-infected mosquito deployments to reduce dengue incidence in Yogyakarta, Indonesia: study protocol for a cluster randomised controlled trial. Trials 19:1.
Crossref
Crossref
Joseph A Lewnard, Christine Tedijanto, Benjamin J Cowling & Marc Lipsitch. (2018) Measurement of Vaccine Direct Effects Under the Test-Negative Design. American Journal of Epidemiology 187:12, pages 2686-2697.
Crossref
Crossref
Mei Shang, Jessie R. Chung, Michael L. Jackson, Lisa A. Jackson, Arnold S. Monto, Emily T. Martin, Edward A. Belongia, Huong Q. McLean, Manjusha Gaglani, Kempapura Murthy, Richard K. Zimmerman, Mary Patricia Nowalk, Alicia M. Fry & Brendan Flannery. (2018) Influenza vaccine effectiveness among patients with high-risk medical conditions in the United States, 2012–2016. Vaccine 36:52, pages 8047-8053.
Crossref
Crossref
Shuo Feng, Susan S Chiu, Eunice L Y Chan, Mike Y W Kwan, Joshua S C Wong, Chi-Wai Leung, Yiu Chung Lau, Sheena G Sullivan, J S Malik Peiris & Benjamin J Cowling. (2018) Effectiveness of influenza vaccination on influenza-associated hospitalisations over time among children in Hong Kong: a test-negative case-control study. The Lancet Respiratory Medicine 6:12, pages 925-934.
Crossref
Crossref
Ian G. Barr, Ruben O. Donis, Jacqueline M. Katz, John W. McCauley, Takato Odagiri, Heidi Trusheim, Theodore F. Tsai & David E. Wentworth. (2018) Cell culture-derived influenza vaccines in the severe 2017–2018 epidemic season: a step towards improved influenza vaccine effectiveness. npj Vaccines 3:1.
Crossref
Crossref
Katherine L Anders, Zoe Cutcher, Immo Kleinschmidt, Christl A Donnelly, Neil M Ferguson, Citra Indriani, Peter A Ryan, Scott L O’Neill, Nicholas P Jewell & Cameron P Simmons. (2018) Cluster-Randomized Test-Negative Design Trials: A Novel and Efficient Method to Assess the Efficacy of Community-Level Dengue Interventions. American Journal of Epidemiology 187:9, pages 2021-2028.
Crossref
Crossref
Mark G. Thompson, Nevil Pierse, Q. Sue Huang, Namrata Prasad, Jazmin Duque, E. Claire Newbern, Michael G. Baker, Nikki Turner & Colin McArthur. (2018) Influenza vaccine effectiveness in preventing influenza-associated intensive care admissions and attenuating severe disease among adults in New Zealand 2012–2015. Vaccine 36:39, pages 5916-5925.
Crossref
Crossref
Michael Haber, Benjamin A. Lopman, Jacqueline E. Tate, Meng Shi & Umesh D. Parashar. (2018) A comparison of the test-negative and traditional case-control study designs with respect to the bias of estimates of rotavirus vaccine effectiveness. Vaccine 36:33, pages 5071-5076.
Crossref
Crossref
A. Machado, I. Kislaya, B. Nunes, A.P. Rodrigues & R. Guiomar. (2018) Moderate influenza vaccine effectiveness in a B mismatch season: Preliminary results from the 2017/2018 season in Portugal. Pulmonology 24:4, pages 260-262.
Crossref
Crossref
Allen C Cheng & Kanta Subbarao. (2018) Epidemiological Data on the Effectiveness of Influenza Vaccine—Another Piece of the Puzzle. The Journal of Infectious Diseases 218:2, pages 176-178.
Crossref
Crossref
Karene Hoi Ting Yeung, Kate Ching Ching Chan, Paul K.S. Chan, David Shu Yan Lam, Philip Chak On Sham, Yat Sun Yau, Wai Hung Chan, Wa Keung Chiu, Kwok Leung Ng, Daniel Kwok Keung Ng, Iris Mei Ching Chan & E. Anthony S. Nelson. (2018) Influenza vaccine effectiveness in hospitalised Hong Kong children: Feasibility of estimates from routine surveillance data. Vaccine 36:24, pages 3477-3485.
Crossref
Crossref
Nathalie El Omeiri, Eduardo Azziz-Baumgartner, Mark G. Thompson, Wilfrido Clará, Mauricio Cerpa, Rakhee Palekar, Sara Mirza & Alba María Ropero-Álvarez. (2018) Seasonal influenza vaccine effectiveness against laboratory-confirmed influenza hospitalizations – Latin America, 2013. Vaccine 36:24, pages 3555-3566.
Crossref
Crossref
John M McLaughlin, Qin Jiang, Raul E Isturiz, Heather L Sings, David L Swerdlow, Bradford D Gessner, Ruth M Carrico, Paula Peyrani, Timothy L Wiemken, William A Mattingly, Julio A Ramirez & Luis Jodar. (2018) Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine Against Hospitalization for Community-Acquired Pneumonia in Older US Adults: A Test-Negative Design. Clinical Infectious Diseases.
Crossref
Crossref
Annette K. Regan, Robyn A. Gibbs & Paul V. Effler. (2018) An audit of the reliability of influenza vaccination and medical information extracted from eHealth records in general practice. Vaccine 36:23, pages 3195-3198.
Crossref
Crossref
Natsumi Shibata, Shinya Kimura, Takahiro Hoshino, Masato Takeuchi & Hisashi Urushihara. (2018) Effectiveness of influenza vaccination for children in Japan: Four-year observational study using a large-scale claims database. Vaccine 36:20, pages 2809-2815.
Crossref
Crossref
Susan S Chiu, Mike Y W Kwan, Shuo Feng, Joshua S C Wong, Chi-Wai Leung, Eunice L Y Chan, Kwok-Hung Chan, Tak-Keung Ng, Wing-Kin To, Benjamin J Cowling & J S Malik Peiris. (2018) Influenza Vaccine Effectiveness Against Influenza A(H3N2) Hospitalizations in Children in Hong Kong in a Prolonged Season, 2016/2017. The Journal of Infectious Diseases 217:9, pages 1365-1371.
Crossref
Crossref
Kylie E. C. Ainslie, Michael J. Haber, Ryan E. Malosh, Joshua G. Petrie & Arnold S. Monto. (2018) Maximum likelihood estimation of influenza vaccine effectiveness against transmission from the household and from the community. Statistics in Medicine 37:6, pages 970-982.
Crossref
Crossref
Susan S Chiu, Mike Y W Kwan, Shuo Feng, Joshua S C Wong, Chi-Wai Leung, Eunice L Y Chan, J S Malik Peiris & Benjamin J Cowling. (2018) Interim estimate of influenza vaccine effectiveness in hospitalised children, Hong Kong, 2017/18. Eurosurveillance 23:8.
Crossref
Crossref
Ainara Mira-Iglesias, F Xavier López-Labrador, Beatriz Guglieri-López, Miguel Tortajada-Girbés, Víctor Baselga-Moreno, Laura Cano, Juan Mollar-Maseres, Mario Carballido-Fernández, Germán Schwarz-Chavarri, Javier Díez-Domingo & Joan Puig-Barberà. (2018) Influenza vaccine effectiveness in preventing hospitalisation of individuals 60 years of age and over with laboratory-confirmed influenza, Valencia Region, Spain, influenza season 2016/17. Eurosurveillance 23:8.
Crossref
Crossref
Shuo Feng, Benjamin J Cowling, Heath Kelly & Sheena G Sullivan. (2018) Estimating Influenza Vaccine Effectiveness With the Test-Negative Design Using Alternative Control Groups: A Systematic Review and Meta-Analysis. American Journal of Epidemiology 187:2, pages 389-397.
Crossref
Crossref
Justin R. Ortiz, Julian Hickling, Rebecca Jones, Armen Donabedian, Othmar G. Engelhardt, Jacqueline M. Katz, Shabir A. Madhi, Kathleen M. Neuzil, Guus F. Rimmelzwaan, James Southern, David J. Spiro & Joachim Hombach. (2018) Report on eighth WHO meeting on development of influenza vaccines that induce broadly protective and long-lasting immune responses: Chicago, USA, 23–24 August 2016. Vaccine 36:7, pages 932-938.
Crossref
Crossref
Jesús Castilla, Iván Martínez-Baz, Ana Navascués, Itziar Casado, Aitziber Aguinaga, Jorge Díaz-González, Josu Delfrade, Marcela Guevara & Carmen Ezpeleta. (2018) Comparison of influenza vaccine effectiveness in preventing outpatient and inpatient influenza cases in older adults, northern Spain, 2010/11 to 2015/16. Eurosurveillance 23:2.
Crossref
Crossref
Michelle A Gill & Elizabeth P Schlaudecker. (2017) Perspectives from the Society for Pediatric Research: Decreased Effectiveness of the Live Attenuated Influenza Vaccine. Pediatric Research 83:1, pages 31-40.
Crossref
Crossref
Michael L. Jackson, C. Hallie Phillips, Joyce Benoit, Erika Kiniry, Lawrence Madziwa, Jennifer C. Nelson & Lisa A. Jackson. (2018) The impact of selection bias on vaccine effectiveness estimates from test-negative studies. Vaccine 36:5, pages 751-757.
Crossref
Crossref
Anika Singanayagam, Maria Zambon, Ajit Lalvani & Wendy Barclay. (2018) Urgent challenges in implementing live attenuated influenza vaccine. The Lancet Infectious Diseases 18:1, pages e25-e32.
Crossref
Crossref
Joseph S. Bresee, Alicia M. Fry, Suryaprakash Sambhara & Nancy J. Cox. 2018. Plotkin's Vaccines. Plotkin's Vaccines
456
488.e21
.
Kylie E.C. Ainslie, Meng Shi, Michael Haber & Walter A. Orenstein. (2017) On the bias of estimates of influenza vaccine effectiveness from test–negative studies. Vaccine 35:52, pages 7297-7301.
Crossref
Crossref
Joan Puig-Barberà, Beatriz Guglieri-López, Miguel Tortajada-Girbés, F. Xavier López-Labrador, Mario Carballido-Fernández, Joan Mollar-Maseres, Germán Schwarz-Chavarri, Víctor Baselga-Moreno, Ainara Mira-Iglesias & Javier Díez-Domingo. (2017) Low influenza vaccine effectiveness and the effect of previous vaccination in preventing admission with A(H1N1)pdm09 or B/Victoria-Lineage in patients 60 years old or older during the 2015/2016 influenza season. Vaccine 35:52, pages 7331-7338.
Crossref
Crossref
Marc Rondy, Nathalie El Omeiri, Mark G. Thompson, Alain Levêque, Alain Moren & Sheena G. Sullivan. (2017) Effectiveness of influenza vaccines in preventing severe influenza illness among adults: A systematic review and meta-analysis of test-negative design case-control studies. Journal of Infection 75:5, pages 381-394.
Crossref
Crossref
Catharine Paules & Kanta Subbarao. (2017) Influenza. The Lancet 390:10095, pages 697-708.
Crossref
Crossref
Ewan P. Plant, Lucy J. Fredell, Blake A. Hatcher, Xing Li, Meng-Jung Chiang, Martina Kosikova, Hang Xie, Olga Zoueva, Angelia A. Cost, Zhiping Ye & Michael J. Cooper. (2017) Different Repeat Annual Influenza Vaccinations Improve the Antibody Response to Drifted Influenza Strains. Scientific Reports 7:1.
Crossref
Crossref
Shuo Feng, Ashley L. Fowlkes, Andrea Steffens, Lyn Finelli & Benjamin J. Cowling. (2017) Assessment of Virus Interference in a Test-negative Study of Influenza Vaccine Effectiveness. Epidemiology 28:4, pages 514-524.
Crossref
Crossref
Alin Gherasim, Iván Martínez-Baz, Jesús Castilla, Francisco Pozo & Amparo Larrauri. (2017) Effect of previous and current vaccination against influenza A(H1N1)pdm09, A(H3N2), and B during the post-pandemic period 2010-2016 in Spain. PLOS ONE 12:6, pages e0179160.
Crossref
Crossref
Allen C. Cheng, Kristine K. Macartney, Grant W. Waterer, Tom Kotsimbos, Paul M. Kelly, Christopher C. Blyth, Saliya HewagamaSanjaya SenenayakeDeborah FriedmanGraham SimpsonPeter WarkCameron HunterTony KormanJohn UphamSimon BowlerMark HolmesLouis IrvingSimon BrownGrant WatererDominic E. Dwyer. (2017) Repeated Vaccination Does Not Appear to Impact Upon Influenza Vaccine Effectiveness Against Hospitalization With Confirmed Influenza. Clinical Infectious Diseases 64:11, pages 1564-1572.
Crossref
Crossref
Brendan Flannery, Sue B. Reynolds, Lenee Blanton, Tammy A. Santibanez, Alissa O’Halloran, Peng-Jun Lu, Jufu Chen, Ivo M. Foppa, Paul Gargiullo, Joseph Bresee, James A. Singleton & Alicia M. Fry. (2017) Influenza Vaccine Effectiveness Against Pediatric Deaths: 2010–2014. Pediatrics 139:5.
Crossref
Crossref
Eva van Doorn, Maryam Darvishian, Frederika Dijkstra, Gé A. Donker, Pieter Overduin, Adam Meijer & Eelko Hak. (2017) Influenza vaccine effectiveness estimates in the Dutch population from 2003 to 2014: The test-negative design case-control study with different control groups. Vaccine 35:21, pages 2831-2839.
Crossref
Crossref
Yi Zhang, Peng Wu, Luzhao Feng, Peng Yang, Yang Pan, Shuo Feng, Ying Qin, Jiandong Zheng, Joan Puig-Barberà, David Muscatello, Raina MacIntyre, Benjamin J. Cowling, Hongjie Yu & Quanyi Wang. (2017) Influenza vaccine effectiveness against influenza-associated hospitalization in 2015/16 season, Beijing, China. Vaccine 35:23, pages 3129-3134.
Crossref
Crossref
Jill M. Ferdinands, Ivo M. Foppa, Alicia M. Fry, Brendan L. Flannery, Edward A. Belongia & Michael L. Jackson. (2017) RE: “INVITED COMMENTARY: BEWARE THE TEST-NEGATIVE DESIGN”. American Journal of Epidemiology 185:7, pages 613-613.
Crossref
Crossref
James E Fielding. (2017) Influenza vaccine effectiveness using the test-negative design: comparability and methodological challenges in meta-analyses. The Lancet Respiratory Medicine 5:3, pages 161-162.
Crossref
Crossref
Alan Hampson, Ian Barr, Nancy Cox, Ruben O. Donis, Hirve Siddhivinayak, Daniel Jernigan, Jacqueline Katz, John McCauley, Fernando Motta, Takato Odagiri, John S. Tam, Anthony Waddell, Richard Webby, Thedi Ziegler & Wenqing Zhang. (2017) Improving the selection and development of influenza vaccine viruses – Report of a WHO informal consultation on improving influenza vaccine virus selection, Hong Kong SAR, China, 18–20 November 2015. Vaccine 35:8, pages 1104-1109.
Crossref
Crossref
Benjamin J. Cowling, Mike Y. W. Kwan, Joshua S. C. Wong, Shuo Feng, Chi-Wai Leung, Eunice L. Y. Chan, Kwok-Hung Chan, Tak-Keung Ng, Wing-Kin To, Malik J. S. Peiris & Susan S. Chiu. (2017) Interim estimates of the effectiveness of influenza vaccination against influenza-associated hospitalization in children in Hong Kong, 2015-16. Influenza and Other Respiratory Viruses 11:1, pages 61-65.
Crossref
Crossref
Theodore Lytras, Athanasios Kossyvakis, Angeliki Melidou, Anastasia Andreopoulou, Maria Exindari, Georgia Gioula, Antonios Kalliaropoulos, Kyriaki Tryfinopoulou, Vasiliki Pogka, Georgia Spala, Nikolaos Malisiovas & Andreas Mentis. (2016) Influenza vaccine effectiveness in preventing hospitalizations with laboratory-confirmed influenza in Greece during the 2014-2015 season: A test-negative study. Journal of Medical Virology 88:11, pages 1896-1904.
Crossref
Crossref
Norio Sugaya, Masayoshi Shinjoh, Chiharu Kawakami, Yoshio Yamaguchi, Makoto Yoshida, Hiroaki Baba, Mayumi Ishikawa, Mio Kono, Shinichiro Sekiguchi, Takahisa Kimiya, Keiko Mitamura, Motoko Fujino, Osamu Komiyama, Naoko Yoshida, Kenichiro Tsunematsu, Atsushi Narabayashi, Yuji Nakata, Akihiro Sato, Nobuhiko Taguchi, Hisayo Fujita, Machiko Toki, Michiko Myokai, Ichiro Ookawara & Takao Takahashi. (2016) Trivalent inactivated influenza vaccine effective against influenza A(H3N2) variant viruses in children during the 2014/15 season, Japan. Eurosurveillance 21:42.
Crossref
Crossref
Wanitchaya Kittikraisak, Piyarat Suntarattiwong, Darunee Ditsungnoen, Chonticha Klungthong, Stefan Fernandez, In-Kyu Yoon, Kim Lindblade, Fatimah S. Dawood, Sonja J. Olsen & Tawee Chotpitayasunondh. (2016) Effectiveness of the 2013 and 2014 Southern Hemisphere Influenza Vaccines Against Laboratory-confirmed Influenza in Young Children Using a Test-negative Design, Bangkok, Thailand. Pediatric Infectious Disease Journal 35:10, pages e318-e325.
Crossref
Crossref
Pasi M Penttinen & Martin H Friede. (2016) Decreased effectiveness of the influenza A(H1N1)pdm09 strain in live attenuated influenza vaccines: an observational bias or a technical challenge?. Eurosurveillance 21:38.
Crossref
Crossref
Sheena G. Sullivan, Eric J. Tchetgen Tchetgen & Benjamin J. Cowling. (2016) Theoretical Basis of the Test-Negative Study Design for Assessment of Influenza Vaccine Effectiveness. American Journal of Epidemiology 184:5, pages 345-353.
Crossref
Crossref
James E. Fielding, Avram Levy, Monique B. Chilver, Yi-Mo Deng, Annette K. Regan, Kristina A. Grant, Nigel P. Stocks & Sheena G. Sullivan. (2016) Effectiveness of seasonal influenza vaccine in Australia, 2015: An epidemiological, antigenic and phylogenetic assessment. Vaccine 34:41, pages 4905-4912.
Crossref
Crossref
S. G. SULLIVAN, K. S. CARVILLE, M. CHILVER, J. E. FIELDING, K. A. GRANT, H. KELLY, A. LEVY, N. P. STOCKS, S. S. TEMPONE & A. K. REGAN. (2016) Pooled influenza vaccine effectiveness estimates for Australia, 2012–2014. Epidemiology and Infection 144:11, pages 2317-2328.
Crossref
Crossref
James E Fielding. (2016) Methodological evolution of influenza vaccine effectiveness assessment. The Lancet Infectious Diseases 16:8, pages 874-875.
Crossref
Crossref
Edward A Belongia, Melissa D Simpson, Jennifer P King, Maria E Sundaram, Nicholas S Kelley, Michael T Osterholm & Huong Q McLean. (2016) Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies. The Lancet Infectious Diseases 16:8, pages 942-951.
Crossref
Crossref
Danuta M. Skowronski, Catharine Chambers, Suzana Sabaiduc, Gaston De Serres, Anne-Luise Winter, James A. Dickinson, Mel Krajden, Jonathan B. Gubbay, Steven J. Drews, Christine Martineau, Alireza Eshaghi, Trijntje L. Kwindt, Nathalie Bastien & Yan Li. (2016) A Perfect Storm: Impact of Genomic Variation and Serial Vaccination on Low Influenza Vaccine Effectiveness During the 2014–2015 Season. Clinical Infectious Diseases 63:1, pages 21-32.
Crossref
Crossref
H. S. BOND, S. G. SULLIVAN & B. J. COWLING. (2016) Regression approaches in the test-negative study design for assessment of influenza vaccine effectiveness. Epidemiology and Infection 144:8, pages 1601-1611.
Crossref
Crossref
Vivian K Leung, Benjamin J Cowling, Shuo Feng & Sheena G Sullivan. (2016) Concordance of interim and final estimates of influenza vaccine effectiveness: a systematic review. Eurosurveillance 21:16.
Crossref
Crossref
Ying Qin, Yi Zhang, Peng Wu, Shuo Feng, Jiandong Zheng, Peng Yang, Yang Pan, Quanyi Wang, Luzhao Feng, Xinghuo Pang, Joan Puig-Barberà, Hongjie Yu & Benjamin J. Cowling. (2016) Influenza vaccine effectiveness in preventing hospitalization among Beijing residents in China, 2013–15. Vaccine 34:20, pages 2329-2333.
Crossref
Crossref
Susan S. Chiu, Shuo Feng, Kwok-Hung Chan, Janice Y.C. Lo, Eunice L.Y. Chan, Lok-Yee So, Benjamin J. Cowling & J.S. Malik Peiris. (2016) Hospital-based vaccine effectiveness against influenza B lineages, Hong Kong, 2009−14. Vaccine 34:19, pages 2164-2169.
Crossref
Crossref
Shuo Feng, Benjamin J. Cowling & Sheena G. Sullivan. (2016) Influenza vaccine effectiveness by test-negative design – Comparison of inpatient and outpatient settings. Vaccine 34:14, pages 1672-1679.
Crossref
Crossref
Jessie R. ChungBrendan FlanneryMark G. ThompsonManjusha GaglaniMichael L. JacksonArnold S. MontoMary Patricia NowalkH. Keipp TalbotJohn J. Treanor, Edward A. Belongia, Kempapura MurthyLisa A. JacksonJoshua G. PetrieRichard K. ZimmermanMarie R. GriffinHuong Q. McLean & Alicia M. Fry. (2016) Seasonal Effectiveness of Live Attenuated and Inactivated Influenza Vaccine. Pediatrics 137:2.
Crossref
Crossref
C.R. Lane, K.S. Carville, N. Pierse & H.A. Kelly. (2016) Seasonal influenza vaccine effectiveness estimates: Development of a parsimonious case test negative model using a causal approach. Vaccine 34:8, pages 1070-1076.
Crossref
Crossref
Benjamin J. Cowling, Shuo Feng, Lyn Finelli, Andrea Steffens & Ashley Fowlkes. (2016) Assessment of influenza vaccine effectiveness in a sentinel surveillance network 2010–13, United States. Vaccine 34:1, pages 61-66.
Crossref
Crossref
Christopher C. Blyth, Allen C. Cheng, Carolyn Finucane, Peter Jacoby, Paul V. Effler, David W. Smith, Heath Kelly, Kristine K. Macartney & Peter C. Richmond. (2015) The effectiveness of influenza vaccination in preventing hospitalisation in children in Western Australia. Vaccine 33:51, pages 7239-7244.
Crossref
Crossref
Allen C. Cheng, Tom Kotsimbos & Paul M. Kelly. (2015) Influenza vaccine effectiveness against hospitalisation with influenza in adults in Australia in 2014. Vaccine 33:51, pages 7352-7356.
Crossref
Crossref
Sheena G. Sullivan & Benjamin J. Cowling. (2015) “Crude Vaccine Effectiveness” Is a Misleading Term in Test-negative Studies of Influenza Vaccine Effectiveness. Epidemiology 26:5, pages e60.
Crossref
Crossref
Danuta M. Skowronski, Catharine Chambers, Suzana Sabaiduc, Gaston De Serres, Anne-Luise Winter, James A. Dickinson, Jonathan Gubbay, Kevin Fonseca, Hugues Charest, Mel Krajden, Martin Petric, Salaheddin M. Mahmud, Paul Van Caeseele, Nathalie Bastien, Alireza Eshaghi & Yan Li. (2015) Integrated Sentinel Surveillance Linking Genetic, Antigenic, and Epidemiologic Monitoring of Influenza Vaccine-Virus Relatedness and Effectiveness During the 2013–2014 Influenza Season. Journal of Infectious Diseases 212:5, pages 726-739.
Crossref
Crossref
Masayoshi Shinjoh, Norio Sugaya, Yoshio Yamaguchi, Yuka Tomidokoro, Shinichiro Sekiguchi, Keiko Mitamura, Motoko Fujino, Hiroyuki Shiro, Osamu Komiyama, Nobuhiko Taguchi, Yuji Nakata, Naoko Yoshida, Atsushi Narabayashi, Michiko Myokai, Masanori Sato, Munehiro Furuichi, Hiroaki Baba, Hisayo Fujita, Akihiro Sato, Ichiro Ookawara, Kenichiro Tsunematsu, Makoto Yoshida, Mio Kono, Fumie Tanaka, Chiharu Kawakami, Takahisa Kimiya, Takao Takahashi & Satoshi Iwata. (2015) Effectiveness of Trivalent Inactivated Influenza Vaccine in Children Estimated by a Test-Negative Case-Control Design Study Based on Influenza Rapid Diagnostic Test Results. PLOS ONE 10:8, pages e0136539.
Crossref
Crossref
Raúl Ortiz de Lejarazu & Sonia Tamames. (2015) Vacunación antigripal. Efectividad de las vacunas actuales y retos de futuro. Enfermedades Infecciosas y Microbiología Clínica 33:7, pages 480-490.
Crossref
Crossref
Silvia Jiménez-Jorge, Francisco Pozo & Amparo Larrauri. (2015) Interim influenza vaccine effectiveness: A good proxy for final estimates in Spain in the seasons 2010–2014. Vaccine 33:29, pages 3276-3280.
Crossref
Crossref
J Puig-Barberà, A Mira-Iglesias, M Tortajada-Girbés, F X López-Labrador, A Belenguer-Varea, M Carballido-Fernández, E Carbonell-Franco, C Carratalá-Munuera, R Limón-Ramírez, J Mollar-Maseres, M del Carmen Otero-Reigada, G Schwarz-Chavarri, J Tuells & V Gil-Guillén. (2015) Effectiveness of influenza vaccination programme in preventing hospital admissions, Valencia, 2014/15 early results. Eurosurveillance 20:8.
Crossref
Crossref